Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer’s Disease in the United States von Boustani, Malaz, Doty, Erin G., Garrison Jr, Louis P., Smolen, Lee J., Klein, Timothy M., Murphy, Daniel R., Spargo, Andrew W., Belger, Mark, Johnston, Joseph A.

Volltext

New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement von Buck, Philip O, Gomes, Dumingu Aparna, Beck, Ekkehard, Kirson, Noam, Mattera, Matthew, Carroll, Stuart, Ultsch, Bernhard, Jayasundara, Kavisha, Uhart, Mathieu, Garrison, Jr, Louis P

Volltext

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study von Guzauskas, Gregory F., Pollom, Erqi L., Stieber, Volker W., Wang, Bruce C.M., Garrison Jr, Louis P.

Volltext

Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] von Lakdawalla, Darius N., Doshi, Jalpa A., Garrison, Louis P., Phelps, Charles E., Basu, Anirban, Danzon, Patricia M.

Volltext

Val (EU) xit: do we need an international ISPOR value flower? von Ramagopalan, Sreeram V, Gomes, Manuel, Durand-Zaleski, Isabelle, Malcolm, Bill, Diaz, Jose, Mitchell, Grace, Pearson-Stuttard, Jonathan, Garrison, Jr, Louis P

Volltext

Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next? von Garrison, Jr, Louis P

Volltext

Paying for Kidneys: Reflections on Welfare Economics, Political Economy, and Market Design von Garrison, Louis P.

Volltext

Value-Based Pricing for Patent-Protected Medicines Over the Product Life Cycle: Pricing Anomalies in the “Age of Cures” and Their Implications for Dynamic Efficiency von Garrison, Louis P., Jiao, Boshen, Dabbous, Omar

Volltext

Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019 von Garrison, Louis P., Jiao, Boshen, Elsisi, Zizi, Yehoshua, Alon, Koruth, Roy, Kreter, Bruce, Grueger, Jens

Volltext

Can’t Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products... von Towse, Adrian, Garrison, Louis P.

Volltext

Why is the market design for innovative pharmaceuticals not well understood? von Olivença, Francisco, Diaz, Jose, Ramagopalan, Sreeram V, Garrison, Jr, Louis P

Volltext

Stakeholder Perspectives on a Risk-Benefit Framework for Genetic Testing von Roth, Joshua A., Garrison, Louis P., Burke, Wylie, Ramsey, Scott D., Carlson, Rick, Veenstra, David L.

Volltext

Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women von Duarte, Horacio A., Babigumira, Joseph B., Enns, Eva A., Stauffer, David C., Shafer, Robert W., Beck, Ingrid A., Garrison, Louis P., Chung, Michael H., Frenkel, Lisa M., Bendavid, Eran

Volltext

An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report [2] von Garrison, Louis P., Pauly, Mark V., Willke, Richard J., Neumann, Peter J.

Volltext

Performance-Based Risk-Sharing Arrangements: An Updated International Review von Carlson, Josh J., Chen, Shuxian, Garrison, Louis P.

Volltext

A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report [1] von Neumann, Peter J., Willke, Richard J., Garrison, Louis P.

Volltext

Editorial: On the Benefits of Modeling Using QALYs for Societal Resource Allocation: The Model Is the Message von Garrison, Louis P., PhD

Volltext

Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies von Garrison, Louis P, Jiao, Boshen, Dabbous, Omar

Volltext

Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework von Jiao, Boshen, Carlson, Josh J., Garrison, Louis P., Basu, Anirban

Volltext

Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis von Garrison, Louis P., PhD, Kamal-Bahl, Sachin, PhD, Towse, Adrian, MA, MPhil

Volltext